Susquehanna Fundamental Investments’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,727
| Closed | -$32.5K | – | 964 |
|
|
2024
Q1 | $32.5K | Buy |
+11,727
| New | +$32.5K | ﹤0.01% | 665 |
|
|
2023
Q4 | – | Sell |
-116,363
| Closed | -$120K | – | 184 |
|
|
2023
Q3 | $120K | Sell |
116,363
-109,539
| -48% | -$113K | 0.01% | 344 |
|
|
2023
Q2 | $262K | Sell |
225,902
-24,514
| -10% | -$28.4K | 0.01% | 545 |
|
|
2023
Q1 | $378K | Sell |
250,416
-9,365
| -4% | -$14.1K | 0.01% | 739 |
|
|
2022
Q4 | $649K | Buy |
+259,781
| New | +$649K | 0.01% | 783 |
|
|
2022
Q1 | – | Sell |
-13,319
| Closed | -$122K | – | 1596 |
|
|
2021
Q4 | $122K | Sell |
13,319
-116,728
| -90% | -$1.07M | ﹤0.01% | 1316 |
|
|
2021
Q3 | $1.39M | Buy |
130,047
+75,959
| +140% | +$812K | 0.03% | 733 |
|
|
2021
Q2 | $839K | Buy |
+54,088
| New | +$839K | 0.02% | 932 |
|